skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

65 Total results for product and free and sample content found

Biomedtracker

2018 JP Morgan Healthcare Conference Review

25 Jan 2018

Don't miss out on this comprehensive review of all the presentations from the conference, complied by our analysts, with key points and expert insight, for you to download, for free. A full list of events and catalysts that were announced or updated during the conference is included in this report.

Topic Strategy

Citeline, Trialtrove

Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm

25 Jan 2018

Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.

Trialtrove

Sepsis and the Receding Grail

05 Jan 2018

Sepsis is a life-threatening illness culminating in multi-organ dysfunction paired with a systemic inflammatory response. The disease burden is considerable: it is the single most expensive condition treated in hospitals, with annual costs in the US projected at nearly $24bn.

Trialtrove, Chinatrove

Is China the Dark Horse in Clinical Development?

By ​Heidi Chen 30 Nov 2017

Over the last decade, it is undeniable that China has emerged as a rising star in pharmaceutical R&D

Topic Clinical trials

Chinatrove, Sitetrove

Bioequivalence Trials in China and the Increased Need for Reliable CROs

By Christina DeRuzza 24 Nov 2017

China’s 13th five-year plan 2016–20 will move the country into the center of the international stage of drug development, where they will be global innovators in the industry and more competitive than ever with foreign firms.

Topic Clinical trials Drug review

Trialtrove

2016 Clinical Trials Roundup

27 Jul 2017

Information for 2016 Clinical Trials Roundup comes in part from Citeline’s Trialtrove, one of the essential tools in the Informa Pharma Intelligence suite of products.

Topic Clinical trials

Trialtrove

The Coming of Age of Biosimilars in Autoimmune and Inflammatory Diseases

By Laura Runkel 19 Jun 2017

Biosimilars for autoimmune drugs, including humira, remicade, etanercept, rituximab and others, have been in clinical development for several years.

Topic Biosimilars

Citeline

Multiple Sclerosis Landscape: Is there a paradigm shift?

By Christine Blazynski 01 Jun 2017

The standard of care treatment for multiple sclerosis involves immunomodulatory therapy  to relieve and/or modify symptoms; the vast majority of these are large biologic molecules and are administered via injection. 

Topic Multiple Sclerosis

Trialtrove

One Size No Longer Fits All: The Personalized Medicine Trial Landscape

By Doro Shin 31 May 2017

One Size No Longer Fits All comes to you from In Vivo, part of the Informa Pharma Intelligence suite of tools. Leveraging a unique array of news, data, analysis, and consulting products and services.

Topic Personalized Medicine

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: